Arthritis Care of Los Angeles logo

Scleroderma

Expert diagnosis and personalized treatment at Arthritis Care of Los Angeles.

What is Scleroderma?

Scleroderma is a group of autoimmune diseases that cause the skin and connective tissues to harden and tighten. The word scleroderma means 'hard skin.' There are two main types: localized scleroderma, which mainly affects the skin, and systemic sclerosis, which can affect the skin, blood vessels, and internal organs including the lungs, heart, kidneys, and digestive tract. Systemic sclerosis can range from mild to severe. Early diagnosis and careful monitoring are important for managing the condition and protecting vital organs.

Common Symptoms

  • Hardening and tightening of the skin, especially on fingers, hands, and face
  • Raynaud's phenomenon (fingers turning white, blue, then red in cold)
  • Swollen, puffy fingers and hands
  • Thickening of skin on the trunk
  • Joint pain and stiffness
  • Difficulty swallowing (esophageal involvement)
  • Heartburn and acid reflux
  • Shortness of breath (if lungs are affected)
  • Small calcium deposits under the skin
  • Fatigue

Experiencing these symptoms? Get expert care today.

How is Scleroderma Diagnosed?

Diagnosis involves physical examination of the skin, blood tests (ANA, Scl-70, anti-centromere antibodies), nailfold capillaroscopy to examine tiny blood vessels, and assessment of organ involvement through pulmonary function tests, echocardiogram, and CT scans. Dr. Forouzesh performs a thorough evaluation to determine the type and extent of scleroderma and develop a personalized monitoring plan.

Treatment Options

Immunosuppressive Medications

Mycophenolate, methotrexate, or cyclophosphamide to slow skin thickening and treat lung or other organ involvement.

Vascular Medications

Calcium channel blockers, PDE-5 inhibitors, or prostacyclins to manage Raynaud's phenomenon and improve blood flow.

Biologic Therapies

Tocilizumab and other targeted therapies for skin and lung involvement in systemic sclerosis.

Gastrointestinal Management

Proton pump inhibitors and dietary modifications to manage reflux and swallowing difficulties.

Organ Monitoring

Regular pulmonary function tests, echocardiograms, and blood pressure monitoring to detect and treat organ complications early.

Key Statistics

300,000

Americans estimated to have scleroderma

Source: Scleroderma Foundation

4:1

Female to male ratio

Source: American College of Rheumatology

25-55

Most common age of onset (years)

Source: NIH/NIAMS

Frequently Asked Questions

No, scleroderma is not contagious. It is an autoimmune condition and cannot be spread from person to person.
Localized scleroderma affects mainly the skin and underlying tissues. Systemic sclerosis (systemic scleroderma) can affect the skin plus internal organs including lungs, heart, kidneys, and digestive system. Systemic sclerosis requires closer monitoring.
There is currently no cure, but treatments can effectively manage symptoms, slow progression, and protect organs. Research continues to improve treatment options.
Raynaud's causes blood vessels in the fingers and toes to overreact to cold temperatures or stress, turning white, then blue, then red. It is very common in scleroderma and can be managed with medications and cold avoidance.

Ready to Get Expert Care?

Schedule your appointment with Dr. Solomon Forouzesh, MD, FACP, FACR — a board-certified rheumatologist with 50++ years of expertise in arthritis and autoimmune diseases.

Culver City Office

9808 Venice Blvd, Suite 604

Culver City, CA 90232

(310) 204-6811

Encino Office

5400 Balboa Blvd, Suite 103

Encino, CA 91316

(310) 204-6811